Sagimet Biosciences Inc (SGMT)
4.10
+0.20
(+4.99%)
USD |
NASDAQ |
May 01, 16:00
4.10
0.00 (0.00%)
After-Hours: 18:53
Sagimet Biosciences Accounts Payable (Quarterly): 0.186M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.186M |
| September 30, 2023 | 1.702M |
| June 30, 2023 | 2.723M |
| Date | Value |
|---|---|
| March 31, 2023 | 1.461M |
| December 31, 2022 | 1.125M |
| March 31, 2021 | 1.86M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.186M
Minimum
Dec 2023
2.723M
Maximum
Jun 2023
1.510M
Average
1.582M
Median
Accounts Payable (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 28.04M |
| 89bio Inc | 8.585M |
| Viking Therapeutics Inc | 5.225M |
| Akero Therapeutics Inc | 7.038M |
| Arrowhead Pharmaceuticals Inc | 4.46M |